No. Brentuximab is only approved in US.
The patient also needs to meet indications for Brentuximab. Not all patients with CD30+ Hodgkin's lymphoma or anapalstic alrge cell lymphoma are eligible unless the patient's hematologist in US can justify an indication and the patient is willing to pay out of his/her own pocket.
所有跟帖:
• 多謝回複,我會轉達你的信息。 -慕絲- ♀ (0 bytes) () 07/10/2013 postreply 17:51:40